Cyclo Therapeutics And This Other Penny Stock Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at Cyclo Therapeutics, Inc. (NASDAQ:CYTH) and RENN Fund, Inc. (NYSE:RCG) have recently made notable purchases of their companies' shares. CYTH's 10% owner, Rafael Holdings Inc, acquired 4,000,000 shares at an average price of $1.25, costing around $5 million. RCG's President and CEO, Murray Stahl, acquired 419 shares at an average price of $1.85, spending around $775. These transactions may indicate the insiders' confidence in their companies' prospects.
August 04, 2023 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cyclo Therapeutics' 10% owner, Rafael Holdings Inc, has acquired 4,000,000 shares, indicating potential confidence in the company's prospects.
Insider buying is often seen as a positive sign as insiders are expected to have the most knowledge about the company's prospects. The large purchase by Rafael Holdings Inc could indicate a strong belief in the company's future performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
RENN Fund's President and CEO, Murray Stahl, has acquired 419 shares, indicating potential confidence in the company's prospects.
Insider buying is often seen as a positive sign as insiders are expected to have the most knowledge about the company's prospects. The purchase by Murray Stahl could indicate a strong belief in the company's future performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100